In adults with stage 3 CKD, 12 weeks of low-load muscle strength training with blood flow restriction was not associated with severe adverse effects on serum creatinine, cystatin C, eGFR, or urinary creatinine and microalbuminuria, but it may significantly increase albuminuria levels.
Key Findings
Results
Low-load strength training combined with blood flow restriction (Group 4) was associated with a significant increase in albuminuria within the group.
Group 4 showed a significant increase in albuminuria levels (p = 0.048).
Group 4 performed low-load muscle strength training combined with BFR for 12 weeks, 3 times per week.
The authors conclude MST+BFR 'may significantly increase albuminuria levels'.
Results
Between-group differences in serum creatinine were found for the MST+BFR group compared with the control group and the low-load MST group.
Group 4 differed significantly from Group 1 (control) in creatinine (p = 0.032).
Group 4 differed significantly from Group 2 (low-load MST) in creatinine (p = 0.036).
Between-group comparisons used ANOVA/Kruskal-Wallis with Bonferroni post hoc correction.
Results
Estimated GFR based on creatinine (eGFR-Cr) differed significantly between the MST+BFR group and the low-load MST group.
Group 4 vs Group 2 difference in eGFR-Cr: p = 0.032.
eGFR was one of the dependent variables alongside serum creatinine, cystatin C, and microalbuminuria.
Conclusions
MST+BFR was not associated with severe adverse effects on most glomerular function markers.
No severe adverse effects were observed on serum creatinine, cystatin C, eGFR estimates, or urinary creatinine and microalbuminuria levels.
Analysis was by intention-to-treat, with effect sizes reported using Cohen's d and significance at p ≤ 0.05.
Methods
The study enrolled 40 people with CKD stage 3 in a randomized trial with four arms, and the sample had a high burden of comorbidities and low physical activity.
Groups: control (G1), low-load MST (G2), high-load MST (G3), and low-load MST with BFR (G4).
Participants were predominantly male (52.5%), with low physical activity levels (60%), hypertension (87.5%), and diabetes (37.5%).
Protocol: 12 weeks, 3 sessions/week, 30–40 minutes, 3 exercises (single- and multi-joint) per session at progressive intensities.
What This Means
This study looked at whether strength training done with blood flow restriction (BFR) — using cuffs to partly limit blood flow to the working muscles so that light weights give a strong training effect — is safe for the kidneys of people with stage 3 chronic kidney disease. Forty people were randomly assigned to one of four groups: no exercise, light-weight training, heavy-weight training, or light-weight training with BFR. They trained three times a week for 12 weeks, and the researchers measured blood and urine markers of kidney function.
Overall, the BFR training was not linked to severe harmful changes in the main markers of kidney filtration (creatinine, cystatin C, estimated filtration rate) or in urinary creatinine and microalbumin. However, the BFR group did show a statistically significant rise in albuminuria (protein leaking into the urine), and its creatinine and estimated filtration values differed from those of some other groups. Albumin in urine is a possible sign of kidney stress, so this finding may call for caution.
This research suggests that BFR training may be feasible in this population without severe effects on kidney filtration, but the increase in urinary albumin needs further investigation. The study was small (40 people), so larger and longer studies would be needed to understand whether the albumin increase is temporary or meaningful for long-term kidney health.
Check Your Own Numbers
Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.
Caetano A, Oliveira J, Silva A, Cabral Junior C, Cavalcante M, Cirilo-Sousa M. (2026). Effects of muscle strength training with blood flow restriction on glomerular function in people with stage 3 chronic kidney disease.. Jornal brasileiro de nefrologia. https://doi.org/10.1590/2175-8239-JBN-2026-0061en